Does histological assessment accurately distinguish separate primary lung adenocarcinomas from intrapulmonary metastases? A study of paired resected lung nodules in 32 patients using a routine next-generation sequencing panel for driver mutations
- 1 March 2021
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 75 (6) , 390-396
Abstract
Aim: Various approaches have been reported for distinguishing separate primary lung adenocarcinomas from intrapulmonary metastases in patients with two lung nodules. The aim of this study was to determine whether histological assessment is reliable and accurate in distinguishing separate primary lung adenocarcinomas from intrapulmonary metastases using routine molecular findings as an adjunct. Methods: We studied resected tumour pairs from 32 patients with lung adenocarcinomas in different lobes. In 15 of 32 tumour pairs, next-generation sequencing (NGS) for common driver mutations was performed on both nodules. The remainder of tumour pairs underwent limited NGS, or EGFR genotyping. Tumour pairs with different drivers (or one driver/one wild-type) were classified as molecularly unrelated, while those with identical low-frequency drivers were classified as related. Three pathologists independently and blinded to the molecular results categorised tumour pairs as related or unrelated based on histological assessment. Results: Of 32 pairs, 15 were classified as related by histological assessment, and 17 as unrelated. Of 15 classified as related by histology, 6 were classified as related by molecular analysis, 4 were unrelated and 5 were indeterminate. Of 17 classified as unrelated by histology, 14 were classified as unrelated by molecular analysis, none was related and 3 were indeterminate. Histological assessment of relatedness was inaccurate in 4/32 (12.5%) tumour pairs. Conclusions: A small but significant subset of two-nodule adenocarcinoma pairs is inaccurately judged as related by histological assessment, and can be proven to be unrelated by molecular analysis (driver gene mutations), leading to significant downstaging.Keywords
This publication has 20 references indexed in Scilit:
- Synchronous Pulmonary AdenocarcinomasAmerican Journal of Clinical Pathology, 2020
- NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020Journal of the National Comprehensive Cancer Network, 2019
- Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging TherapiesCancer Discovery, 2017
- Genomic heterogeneity of multiple synchronous lung cancerNature Communications, 2016
- Morphological and molecular approach to synchronous non-small cell lung carcinomas: impact on stagingLaboratory Investigation, 2016
- The Clinical Use of Genomic Profiling to Distinguish Intrapulmonary Metastases From Synchronous Primaries in Non–Small-Cell Lung Cancer: A Mini-ReviewClinical Lung Cancer, 2015
- High Discrepancy of Driver Mutations in Patients with NSCLC and Synchronous Multiple Lung Ground-Glass NodulesJournal of Thoracic Oncology, 2015
- Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapyEuropean Respiratory Journal, 2011
- Heterogeneous Distribution of EGFR Mutations Is Extremely Rare in Lung AdenocarcinomaJournal of Clinical Oncology, 2011
- Multiple primary lung cancersThe Journal of Thoracic and Cardiovascular Surgery, 1975